WHO says hydroxychloroquine safety findings expected by mid-June

The World Health Organization (WHO) said on Tuesday that a safety team would review data on hydroxychloroquine by next month, a day after officials cited safety concerns that prompted them to suspend use of the malaria drug in a global trial in COVID-19 patients.